Jean-François Félix

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.

Elyan Partners SAS is a financial investment advisor registered in the unique register maintained by the ORIAS of insurance, banking, and financial intermediaries. Elyan is located at 47, rue du Faubourg Saint Honoré, 75401 Cedex 08, and is controlled by its management team. The private company is based in Paris, France. The French company is the exclusive advisor of Edmond de Rothschild Private Equity for the ERES III and ERES IV funds and advisor of the Privilege 2018 fund. The company benefits from the support of the Edmond de Rothschild group as a minority shareholder. ERES IV invests in mid-sized companies in the biotech ecosystem, online commerce, financial services, and new consumers. Edmond de Rothschild Private Equity creates and develops differentiated investment strategies that provide a lasting response to environmental and social challenges. The company was founded in 2021, and the CEOs are Jean-François Félix and Jérémie Mélin.

Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million.